Filing metadata

Accession number
0001640455-21-000135
Form type
Form 3
Filer
Jounce Therapeutics, Inc.
CIK
CIK 1640455
Filed
Sep 15, 2021
Reporting period
Sep 13, 2021
Description
Initial ownership

Explore SEC Filings Hub